Atlas Trials

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

Clinical trial NCT06613308 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06613308
Sponsor
Capital Medical University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer (NSCLC)
Start date
2024-09-25
Primary completion
2025-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.